Skip to main content
Clinical Trials/NCT02427256
NCT02427256
Completed
Not Applicable

Comparative Study of the Topcon Specular Microscope SP-1P and the Konan Specular Microscope CELLCHEK XL (Predicate Device) for the Measurements of Endothelial Cell Density Measurements, Coefficient of Variation of Endothelial Cell Area, % Hexagonality, Central Corneal Thickness

Topcon Medical Systems, Inc.1 site in 1 country76 target enrollmentFebruary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Corneal Endothelial Cell Loss
Sponsor
Topcon Medical Systems, Inc.
Enrollment
76
Locations
1
Primary Endpoint
Coefficient of variation of endothelial cell area
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The primary objective of this clinical study is to collect additional clinical data to support an FDA 510(k) submission for the Topcon Specular Microscope SP-1P. The secondary objective is to evaluate any adverse events found during the clinical study.

Registry
clinicaltrials.gov
Start Date
February 2015
End Date
February 2015
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Coefficient of variation of endothelial cell area

Time Frame: Single time point - 1 day

Corneal endothelial cell % hexagonality

Time Frame: Single time point - 1 day

Central corneal thickness

Time Frame: Single time point - 1 day

Corneal endothelial cell density

Time Frame: Single time point - 1 day

Study Sites (1)

Loading locations...

Similar Trials